HeartFlow Launches Advanced Interactive Plaque Analysis Platform for Evaluating Patient Risk in Suspected Coronary Artery Disease – Medical Device News Magazine

**HeartFlow Launches Advanced Interactive Plaque Analysis Platform for Evaluating Patient Risk in Suspected Coronary Artery Disease** *Medical Device News Magazine*...

# A Look Inside Canary Wharf’s Advanced Infectious Disease Testing Facility In the heart of London’s bustling financial district, Canary...

**Bon Secours Mercy Health and Philips Announce Multi-Year Strategic Partnership** *Medical Device News Magazine* In a significant move poised to...

**Bon Secours Mercy Health and Philips Announce Long-Term Strategic Partnership** In a significant move poised to reshape the landscape of...

**Novocuff Secures $26 Million in Oversubscribed Series A Funding to Enhance Preterm Birth Prevention Technology** *Medical Device News Magazine* In...

# 9 Innovative Applications of AI in Medical Device Development Artificial Intelligence (AI) is revolutionizing various sectors, and the field...

**Ideal Medical Solutions Honored at 2024 Medical Device Network Excellence Awards** In a remarkable celebration of innovation and excellence in...

**Government Initiates Program to Enhance Local Production of 113 Cost-Effective Medical Devices, Aiming to Reduce Import Reliance** In a significant...

**Digestiva Secures $18.4 Million in Series A Funding – Reported by Medical Device News Magazine** In a significant development within...

**Mabwell Gains NMPA Approval for Clinical Trial of Innovative Nectin-4 Targeting ADC in Triple-Negative Breast Cancer** In a significant stride...

**Immediate Medicare Coverage Announced for Designated Medical Breakthrough Devices by Knobbe Medical** In a landmark decision poised to revolutionize the...

**WHO Introduces MeDevIS: A Cutting-Edge Platform for Worldwide Medical Device Information** In a significant stride towards enhancing global healthcare, the...

# Comprehensive EDA Guidelines on Recall Classification Rules | RegDesk In the realm of medical devices and pharmaceuticals, ensuring product...

# Guidelines on Recall Classification Rules by the EDA ## Introduction The European Medicines Agency (EMA) and the U.S. Food...

# Comprehensive EDA Guidelines for Initiating Product Recalls | RegDesk In the fast-paced world of product manufacturing and distribution, ensuring...

# Exploring the Limits of Our Molecular Understanding In the vast and intricate world of biology, the molecular level serves...

**Applications of Precision Medicine in Healthcare** Precision medicine, also known as personalized medicine, is revolutionizing the healthcare landscape by tailoring...

# Comprehensive Guide to Breathing Apparatus Manufacturing ## Introduction Breathing apparatuses are critical safety devices designed to provide respiratory protection...

**Global Expansion and US Dominance in the Future of Continuous Glucose Monitors** Continuous Glucose Monitors (CGMs) have revolutionized diabetes management,...

**The Future of Continuous Glucose Monitors: Analyzing Global Expansion and US Market Dominance** Continuous Glucose Monitors (CGMs) have revolutionized diabetes...

**The Future of Continuous Glucose Monitors: Global Expansion and Dominance in the US Market** Continuous Glucose Monitors (CGMs) have revolutionized...

# Guideline for On-Site Inspections Under China’s Good Supply Practice (GSP) Issued ## Introduction China’s pharmaceutical industry has been undergoing...

# Guidelines for On-Site Inspections Under China’s Good Supply Practice (GSP) Issued ## Introduction China’s pharmaceutical industry has seen rapid...

**Implementation of China’s New Generalized System of Preferences (GSP) Set for July 1, 2024** China is set to implement a...

**Implementation of China’s New Generalized System of Preferences (GSP) Starting July 1, 2024** China is set to implement a new...

**Implementation of China’s New Generalized System of Preferences (GSP) Effective July 1, 2024** On July 1, 2024, China will implement...

**China’s New Generalized System of Preferences to Take Effect on July 1, 2024** In a significant move aimed at bolstering...

**Nexalin Technology Sets Price for $5.2 Million Public Offering** In a significant move within the medical technology sector, Nexalin Technology,...

**Essential Tips for Preventing Running Injuries: Insights from Medical Device News Magazine** Running is one of the most popular forms...

**Strategies for Reducing Preventable Injuries to Enhance Healthcare in Canada** Preventable injuries represent a significant burden on the Canadian healthcare...

Overview of MHRA Guidance on Registration Dependent on Expiring CE Certificates: A Comprehensive Explanation

Overview of MHRA Guidance on Registration Dependent on Expiring CE Certificates: A Comprehensive Explanation

The Medicines and Healthcare products Regulatory Agency (MHRA) is the regulatory body responsible for ensuring the safety, quality, and efficacy of medicines and medical devices in the United Kingdom. In light of the UK’s departure from the European Union, the MHRA has issued guidance on the registration process for medical devices that are dependent on expiring CE certificates. This article aims to provide a comprehensive explanation of this guidance.

Background:

Before delving into the details of the MHRA guidance, it is essential to understand the context in which it was issued. With Brexit, the UK is no longer part of the European Union’s regulatory framework for medical devices. Previously, medical devices could be placed on the UK market if they had obtained a CE certificate, which demonstrated compliance with EU regulations. However, with the end of the transition period on December 31, 2020, the UK established its own regulatory system.

MHRA Guidance:

The MHRA guidance on registration dependent on expiring CE certificates outlines the steps that medical device manufacturers need to take to continue placing their products on the UK market. It applies to devices that have a valid CE certificate issued by an EU-recognized Notified Body and are currently registered with the MHRA.

1. Grace Period:

To facilitate a smooth transition, the MHRA has introduced a grace period for medical devices with expiring CE certificates. Devices that have a valid CE certificate can continue to be placed on the UK market until June 30, 2023, without requiring a UKCA (UK Conformity Assessed) mark.

2. Registration Process:

During the grace period, manufacturers must register their devices with the MHRA. The registration process involves creating an account on the MHRA’s Device Online Registration System (DORS) and providing relevant information about the device, including its intended purpose, risk classification, and details of the manufacturer.

3. UKCA Mark:

After the grace period ends on June 30, 2023, medical devices must bear the UKCA mark to be placed on the UK market. The UKCA mark indicates that the device meets the UK’s regulatory requirements. Manufacturers will need to obtain UKCA certification from a UK-approved Conformity Assessment Body (CAB) to affix the mark.

4. Transition from CE to UKCA:

To transition from a CE certificate to a UKCA certificate, manufacturers must engage with a UK-approved CAB. The CAB will assess the device’s conformity with the UK’s regulatory requirements, which are largely aligned with the EU’s regulations. The assessment may involve a review of technical documentation, testing, and quality management system audits.

5. Impact on Supply Chain:

The MHRA guidance also addresses the impact on the supply chain. It clarifies that devices placed on the Great Britain market (England, Scotland, and Wales) must comply with the new UK regulations, while devices placed on the Northern Ireland market must continue to meet EU regulations and bear the CE mark.

Conclusion:

The MHRA guidance on registration dependent on expiring CE certificates provides a comprehensive explanation of the steps medical device manufacturers need to take to continue placing their products on the UK market. By following this guidance, manufacturers can ensure compliance with the UK’s regulatory requirements and maintain access to the UK market. It is crucial for manufacturers to familiarize themselves with this guidance and take appropriate actions within the specified timelines to avoid disruptions in their business operations.